Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
Artechouse's Newest Exhibition Uses Latest NASA Images
Artechouse, a digital art studio in New York City, has a new exhibition that lets visitors experience never-before-seen images that the James Webb space telescope captured. Cheddar News takes a peek inside the newest immersive experience.
Report: Shortage of Cancer Drugs
A report said that cancer centers are dealing with shortages of carboplatin and cisplatin, drugs that are used to treat cancers.
Health Expert Offers Tips for Coping with Poor Air Quality
With large swaths of the East Coast blanketed with smog, many are worried about their health. Mangala Narasimhan, director of critical care services at Northwell Health, offers some peace of mind with a handful of expert tips for coping with poor air quality. 
Hawaii's Kilauea Begins Erupting After 3-Month Pause
Kilauea, one of the most active volcanoes in the world, began erupting on Wednesday after a three-month pause, displaying spectacular fountains of mesmerizing, glowing lava that's a safe distance from people and structures in a national park on the Big Island.
Load More